NCT02233504 · Interventional trial
Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)
Overall registry status Completed
Early Phase 1
Conditions High Risk MDS or AML Patients
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory